Cycloartenyl stearate (1a), lupenyl stearate (1b), sitosteryl stearate (1c), and 24-methylenecycloartanyl stearate (1d) (sample 1) from the air-dried leaves of Syzygium samarangense exhibited potent analgesic and anti-infl ammatory activities at effective doses of 6.25 mg/kg body weight and 12.5 mg/kg body weight, respectively. Sample 1 also exhibited negligible toxicity on zebrafi sh embryonic tissues. There were incidences of mortality upon direct exposure of sample 1 to dechorionated embryos, but higher mortality and aberration were observed during intact chorion treatment.
Introduction
Syzygium samarangense (syn. Eugenia javanica Linn.), commonly known as makopa, is grown throughout the Philippines for its fruits. The leaves are used as an antipyretic and a diuretic (Kuo et al., 2004) . The fl owers of S. samarangense are used for the treatment of fever and diarrhea. Four fl avonoids isolated from the hexane extract of S. samarangense showed dose-dependent spasmolytic activity (Ghayur et al., 2006) . Another study reported that 2´,4´-dihydroxy-6´-methoxy-3´,5´-dimethylchalcone from S. samarangense exhibited signifi cant differential cytotoxicity against the MCF-7 cell line and signifi cant selective cytotoxicity against the RAD 52 yeast mutant strain (Amor et al., 2007) . The following compounds isolated from the hexane extract of the leaves of S. samarangense: α-and β-carotene, lupeol, betulin, epi-betulinic acid, 2´,4´-dihydroxy-6´-methoxy-3´-methylchalcone, 2´,4´-dihydroxy-6´-methoxy-3´-methyldihydrochalcone, 2´-hydroxy-4´,6´-dimethoxy-3´-methylchalcone, and β-D-sit osteryl glucoside exhibited signifi cant and selective inhibition of prolyl endopeptidase (Amor et al., 2004 ). An earlier study reported that the methanol extract of S. samarangense leaves exhibited high antidiabetic activity (Villasenor et al., 1998) . A recent study reported that 2´,4´-dihydroxy-6´-methoxy-3´,5´-dimethylchalcone and 5-O-methyl-4´-desmethoxy matteucinol from S. samarangense signifi cantly lowered the blood glucose levels in hyperglycaemic mice when administered 15 min after glucose load, while 2´,4´-dihydroxy-6´-methoxy-3´,5´-dimethylchalcone signifi cantly lowered the blood glucose levels of alloxan diabetic mice (Resurreccion-Magno et al., 2005) .
We report here the analgesic, anti-infl ammatory, and toxic properties of a mixture of cycloartenyl stearate (1a), lupenyl stearate (1b), sitosteryl stearate (1c), and 24-methylenecycloartanyl stearate (1d) (Fig. 1 ) from the dichloromethane extract of the air-dried leaves of Syzygium samarangense.
Materials and Methods

General experimental procedures
NMR spectra were recorded on a Varian Unity Inova (Palo Alto, CA, USA) spectrometer in CDCl 3 at 500 MHz for 1 H NMR and 125 MHz for 13 C NMR spectra. MS was done on a Finnigan MAT LCQ mass spectrometer (San Jose, CA, 
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Isolation
The air-dried S. samarangense leaves (1 kg) were ground in an osterizer, soaked in dichloromethane (DCM) for 3 d, and then fi ltered. The fi ltrate was concentrated under reduced pressure to afford a crude extract (45.86 g) which was chromatographed with increasing portions of acetone in DCM at 10% increment. The DCM and 10% acetone in DCM fractions were combined and rechromatographed in petroleum ether. The more polar fractions were rechromatographed in ethyl acetate with increasing percentage of petroleum ether (0.5%, 1%, 2.5%, and 5%) to afford sample 1 which is a mixture of 1a -1d (1.0 g).
Cycloartenyl stearate (1a):
13 C NMR: δ (ppm) = 31.6 (C-1), 26.8 (C-2), 80.3 (C-3), 39.5 (C-4), 47.2 (C-5), 20.9 (C-6), 28.1 (C-7), 47.8 (C-8), 20.1 (C-9), 26.0 (C-10), 25.8 (C-11), 35.6 (C-12), 45.3 (C-13), 48.8 (C-14) , 32.8 (C-15), 26.5 (C-16), 52.2 (C-17), 18.0 (C-18), 29.8 (C-19), 35.9 (C-20), 18.3 (C-21), 36.3 (C-22) , 25.2 (C-23), 125.2 (C-24), 130.8 (C-25), 17.6 (C-26), 25.7 (C-27), 19.3 (C-28), 15.2 (C-29), 25.4 (C-30), 173.6 (C-1'), 34.8 (C-2'), 31.9 (C-3'), 22.7, 25.2, 29.2 -29.7 (C-4' -C-17'), 14.1 (C-18').
Lupenyl stearate (1b):
13 C NMR: δ (ppm) = 37.8 (C-1), 23.4 (C-2), 80.7 (C-3), 38.54 (C-4), 55.5 (C-5), 18.3 (C-6), 34.3 (C-7), 40.9 (C-8), 50.4 (C-9), 38.1 (C-10), 21.0 (C-11), 25.2 (C-12), 37.2 (C-13), 42.7 (C-14), 27.5 (C-15), 35.6 (C-16), 43.0 (C-17), 48.4 (C-18), 48.0 (C-19) 109.4 (C-30), 173.5 (C-1'), 34.8 (C-2'), 31.9 (C-3'), 22.7, 25.2, 29.2 -29.7 (C-4' -C-17'), 14.1 (C-18').
Sitosteryl stearate (1c):
13 C NMR: δ (ppm) = 37.1 (C-1), 27.8 (C-2), 73.6 (C-3), 38.0 (C-4), 139.7 (C-5), 122.6 (C-6), 31.92 (C-7), 31.89 (C-8), 50.0 (C-9), 36.1 (C-10), 21.0 (C-11), 39.7 (C-13), 42. 
Sample preparation
In the mouse models, the samples were freshly prepared by dissolving the sample in Polysorbate 80 (Tween-80; AJAX, Finechem Pty. Ltd., Taren Point, NSW, Australia) to obtain a dose of 100 mg/ kg body weight (BW), followed by serial dilution with Polysorbate 80 to obtain doses of 6.25, 12.5, 25, and 50 mg/kg BW. In the zebrafi sh toxicity model, the samples were prepared fresh by dissolving the sample in 100% DMSO (dimethyl sulf oxide) followed by serial dilution with embryo media to obtain 5, 10, 20, and 50 μg/mL at a fi nal solvent content of 0.01%.
Experimental animals
A total of 119 male (8 weeks old) ICR albino mice (Mus musculus L.) weighing (19.0  2.0) g were acclimatized for 7 d prior to conducting the bioassay. The animals were obtained from the Bureau of Food and Drugs, Muntinlupa City, Philippines and housed at the animal containment unit of De La Salle University, Manila, Philippines with 12 h daylight and 12 h darkness and free access to food pellets and water. A 13-h fasting period was kept prior to each treatment procedure followed by 2 h for acclimatization prior to each bioassay. Wild-type zebrafi sh embryos were obtained from adult mating, raised at 28 °C as described by Westerfi eld (2007) , and staged according to Kimmel et al. (1995) . Synchronized embryos were collected, dechorionated, and arrayed by a pipette at three embryos per well. All procedures were in accordance with the existing guidelines of the Philippine Association of Laboratory Animal Science (PALAS, 2002) for care and use of laboratory animals and with Administrative Order 40 of the Bureau of Animal Industry relative to Republic Act No. 8485.
Antinociceptive activity
The tail fl ick assay (Grotto and Sulman, 1967) was conducted on mice (n = 14) orally administered with diclofenac (7.14 mg/kg BW) (GX International, Muntinlupa City Philippines) and Polysorbate 80 (0.5 mL/20 g BW) as the positive and negative controls, respectively, and four dosages of sample 1 dissolved in Polysorbate 80. One-third of the distal part of the tail was immersed in a warm water bath (50 °C) 1 h after the treatments. The time the mouse withdrew its tail from the water bath was noted. Percent inhibition was calculated according to the equation: %inhibition = 100 -[(time that the experimental mice attempted to remove their tails/average time that the control mice attempted to remove their tails) · 100].
The acetic acid writhing assay (Raga et al., 2010; Ragasa et al., 2008 Ragasa et al., , 2009 ) was performed. The test animals (n = 14) were orally administered with Polysorbate 80 and diclofenac sodium difenax for the negative and positive controls, respectively, as well as with four dosages of sample 1. After 1 h of treatments, the mice were injected intraperitoneally with 1% glacial acetic acid (Mallinckrodt Chemicals, Pittsburg, NJ, USA). Abdominal stretches of the mice were counted within 10 min upon injection and calculated as the percent inhibition.
Anti-infl ammatory activity
The modifi ed antipleurisy assay (Ragasa et al., 2008 (Ragasa et al., , 2009 ) was performed. The test animals (n = 9) were subjected to light anesthesia with diethyl ether (AJAX, Finechem Pty. Ltd). Immediately after the mice became unconscious, 1% κ-carrageenan (0.15 mL; Marine Development Resources, Quezon City, Philippines) in normal saline solution was carefully injected into the pleural cavity along the right fl ank of the test ani-mal. One h after induction of pleurisy, the four dosages of sample 1 were orally administered to the test animals. Polysorbate 80 and diclofenac were used as negative and positive controls, respectively. After another hour, the mice were sacrifi ced by intraperitoneal injection of 70% ethanol. The pleural cavity of each mouse was opened and washed with 100 μL citrate buffer to collect lung exudates. A portion of the exudates (20 μL) was obtained for white blood cell (WBC) count using an improved Neubauer hemocytometer following a double blind method. In fi ve 1-mm squares of each of the two counting chambers, the number of cells was then counted and computed using the following formula: cell concentration = (no. of cells · dilution factor · 10)/(no. of large hemocytometer squares counted).
Another portion of the exudates (10 μL) was taken and smeared on a glass slide. The slides were fi xed in absolute methanol, then stained using Giemsa solution (4 mg/mL in MeOH/H 2 O, 7:3) for 5 min, and fi nally rinsed in tap water. Polymorphonuclear cells were identifi ed and counted as the maximum percentage anti-infl ammatory effect following a double blind method.
Zebrafi sh toxicity screen (Kitambi et al., 2009) .
Two experiments were performed to determine the toxicity of the test samples on developing zebrafi sh embryos. Experiment 1 was performed on dechorionated and non-dechorionated 24-hourspost-fertilization (hpf) embryos, while experiment 2 was performed on dechorionated and non-dechorionated 36-hpf embryos. The test samples were administered at the beginning of each time point. Observations were made after every 24 h until the end of a 72-h observation period. The embryos were photodocumented using a Nikon StereoZoom100 camera (Kanagawa, Japan). Mortality and signs of abnormal development were noted.
Statistical analysis
The results were analysed using SPSS ver. 13 for Windows. One way analysis of variance was performed to determine the signifi cant effects of the analgesic and anti-infl ammatory potentials of sample 1. The results were considered significant at P  0.05. Signifi cant differences between groups were determined by post hoc analysis at 95% Duncan multiple range fi nding test. Means are present as mean  SD.
Results
Identifi cation of compounds
Silica gel chromatography of the dichloromethane extract of the air-dried leaves of S. samarangense afforded a mixture of cycloartenyl stearate (1a), lupenyl stearate (1b), sitosteryl stearate (1c), and 24-methylenecycloartanyl stearate (1d). Their structures (Fig. 1) were elucidated by extensive 1D and 2D NMR spectroscopy. The fatty acid chain length was determined by the mass spectrum of sample 1 which gave a molecular ion peak at m/z = 694.2 corresponding to the molecular formula C 48 H NMR spectrum of sample 1 indicated resonances for a mixture of compounds as deduced from the integrals and disparity of the single hydrogen peaks. The structure of 1a was confi rmed by comparison of the 13 C NMR data of 1a with those of cycloartenyl acetate (De Pascual Teresa et al., 1987) for the triterpene part and the fatty acid ester 16-hydroxycycloartenyl palmitate (Ragasa et al., 2004) for the fatty acid part, which matched in all essential respects. The structures of 1b and 1d were confi rmed by comparison of their 13 C NMR data with those of lupenyl acetate (Liu et al., 1998) and 24-methylenecycloartanyl acetate (Ragasa et al., 2005) for the triterpene part and the fatty acid ester 16-hydroxycycloartenyl palmitate (Ragasa et al., 2004) for the fatty acid part. The spectra matched in all essential respects. The 13 C NMR data of 1c matched those of sitosteryl palmitate (Parmar et al., 1998) , confi rming its structure.
Analgesic property
The test animals did not exhibit any sign of poisoning such as weight loss, poor grooming, depression, slow refl ex response, and other behavioural manifestations of intoxication (Guevarra et al., 2005) . These behaviours indicate that the doses administered were below the toxic level. Acute investigation of the antinociceptive potential of sample 1 from S. samarangense significantly reduced perception of pain in the visceral model (P = 0.0001) comparable to the effects of diclofenac, but minimal inhibition was observed in the thermal pain model (P = 0.0001) ( Table I ).
In the visceral pain model (acetic acid writhing assay), mice administered with all doses of sample 1 showed reduced writhing response similar to the effects of diclofenac [(51.71  4.93)%]. However, a non-dose-dependent activity was observed with increasing doses of sample 1. In the tail fl ick model, mice orally administered with diclofenac (7.14 mg/kg BW) demonstrated delayed perception of pain [(5.37  0.28) s], i. e. (35.97  3.61)% inhibition compared to the negative control. Minimal inhibitory activity, however, was observed with all doses of sample 1, thus demonstrating low antinociceptive activity (Table I) .
Anti-infl ammatory activity
The anti-infl ammatory activity of sample 1 was investigated using the lung antipleurisy model in mice. Quantifi cation of leukocyte emigration into the pleural cavity using Giemsa-stained blood smear and a white blood cell (WBC) hemocytometer count were performed. Sample 1 administered orally to mice 1 h after induction of pleurisy revealed a signifi cant (P = 0.0001) antiinfl ammatory activity, which is comparable to that of diclofenac (Table II) . The activity was evident in the reduced number of polymorphonuclear cells that emigrated towards the site of carrageen injection. The results obtained from the WBC smear count (P < 0.0001) corroborated with the results obtained from the WBC hemocytometer count (P < 0.0001). Diclofenac reduced the test animals' sensitivity to infl ammatory response with a percent inhibition of (76.60  3.38)% for the WBC smear count and (65.46  4.97)% for the WBC hemocytometer count. The administration of all doses of sample 1 has considerably reduced the concentration of WBC in the lung exudates which also corroborated with the effects observed in the visceral pain model. Furthermore, the relative anti-infl ammatory activity among all doses of sample 1 indicated comparative activity to diclofenac. This also suggests that 12.5 mg sample 1/ kg BW has high impact on the anti-infl ammatory activity. The low-dose requirement necessary to elicit analgesic and anti-infl ammatory potential indicates high impact potential of sample 1.
Toxicity
Toxicity of sample 1 was analysed using zebrafi sh embryos with treatment administrations at 24 hpf and 36 hpf in the dechorionated setup. Another experiment involving 2.5-hpf embryos with intact chorion was also performed. 24-hpf embryos treated with sample 1 had higher mor- tality compared to the negative control. The three highest concentrations of sample 1 led to the lowest percent survival rate which is almost similar to that of the effects of the positive control (79.167%). No mortality, however, was observed beyond 48 hpf (Fig. 2) . Embryos treated with sample 1 at 36 hpf revealed the lowest survival rate at 5 μg/mL (58.33%) and 50 μg/mL (66.67%) observed at 48 hpf. The other two concentrations of the test substance (10 and 20 μg/mL) showed similar survival rates with the positive control, sodium lauryl sulfate (SLS) (70.83%). There was no mortality observed at 72 hpf (Fig. 2B) . Treatment administration of sample 1 on 2.5-hpf embryos with intact chorion revealed decreased survivability compared to the negative control group, DMSO. At 24 hpf, embryos administered with 50 and 20 μg/mL showed the highest mortality (79.167% and 72.917%). Embryo survivability further decreased at 48 hpf in all treatments except for the negative control group which remained 18.75% throughout the observation periods. The results of this study indicate that the treatments had a much higher incidence of mortality in the intact chorion group compared to the dechorionated embryos which may suggest that sample 1 has less severe effects on embryonic development but more on the chorionic membrane. Three morphological abnormalities were observed at the end of the treatment periods namely: curled tail, infl amed heart, and yolk sac edema (Fig. 3) . However, these morphological abnormalities observed in the treatment groups were lower than the observed values in the negative control group (DMSO) (Fig. 3) . There was no incidence of malformed head observed in embryos after all treatments. These observations were almost similar in both 24-hpf and 36-hpf treatment groups. Similar to the dechorionated embryos, there was no incidence of malformed head in the intact chorion group, but an infl amed heart was observed in the 20 and 10 μg/mL sample 1 treatment groups along with yolk sac edema in the 20 μg/mL treatment group, but none were seen in both control groups. The data suggest the possible role of the chorion in protecting the developing embryo from foreign substances. In the experiments with dechorionated embryos, very little difference in Fig. 2 . Survival rate of dechorionated zebrafi sh embryos administered with sample 1 at (A) 24 hpf and (B) 36 hpf, and (C) zebrafi sh embryos with intact chorion at 2.5 hpf. SLS, sodium lauryl sulfate; DMSO, dimethyl sulfoxide. morphological abnormality was observed across treatments indicating that these defects may not have been caused by the treatment with sample 1, but by other external factors.
The frequency of hatching was observed and noted at 72 hpf similar to the reported frequency of hatching in an earlier study (Kimmel et al., 1995) . Most of the embryos with DMSO treatment hatched normally having the highest hatching frequency (43.75%). The hatching frequency of embryos was affected by sample 1 treatments in a dose-related manner. No embryo hatched in 50 μg/mL treatment. The embryos in all sample 1 treatments, however, were observed alive at 72 hpf until 96 hpf, but survivability started to decrease as the age of embryo progressed (Fig. 4) . The results of the current study indicate a possible inhibition of the normal chorionic function which may have caused signifi cant delay in hatching and increased morphological abnormality in the embryos.
Discussion
Sample 1 obtained from S. samarangense demonstrated pain and infl ammation inhibitory effects using the visceral pain model and carrageenan-induced lung pleurisy. Overall, the results illustrated a signifi cant effect in suppressing the perception of acute pain and infl ammation induced in the test animals. The tail fl ick assay specifi cally tests for centrally mediated perception of pain by inhibiting certain opioid receptors (Akter et al., 2008) . The results obtained from this assay showed that the thermal response of the positive control has reduced the perception of pain in the experimental animals, but to a much lesser extent in those mice treated with sample 1.
The acetic acid writhing assay determines the peripheral inhibition of pain by triggering the localized anti-infl ammatory response that is mediated by peritoneal mast cells, acid sensing ion channels, and prostaglandin pathways which are activated when acetic acid is introduced into the system (Akter et al., 2008) . No dose relationship, however, was evident in the experimental animals' response in this assay. All doses tested revealed no signifi cant difference to that of the positive control indicating that sample 1 may be potent in delaying visceral pain perception even at a very low dose comparable to the commercial drug diclofenac. The abdominal stretches observed in the negative control group indicate that there was sensitization of pain in the affected area by the release of free arachidonic acid from some tissue phospholipids which in turn have been transformed to prostaglandins (Hasan et al., 2009) . The acetic acid writhing test is sensitive in examining peripheral acting analgesics through localizing acute infl ammatory responses that could be associated with the presence of prostaglandins (Hasan et al., 2010) . Prostaglandin E2 (PGE2) with other endogenous mediators like prostaglandin F2α (PF2α) and other lipooxygenase products stimulate nociceptive neurons that could result in abdominal responses (De Souza et al., 2009) , thus inhibiting the synthesis of prostaglandin and reducing the writhing frequency in mice (Akter et al., 2008) .
Carrageenan-induced lung pleurisy was used to determine the anti-infl ammatory activity of sample 1. There was a reduced number of WBC in the pleural cavity in mice administered with sample 1 following a non-dose-dependent interaction. Intraperitoneal injection of carrageenan triggers the intense infl ammatory response with the formation of exudates which mainly contain neutrophils (Horakova et al., 1980 ). An increase in the level of mast cells and histamine could indicate the fi rst phase of infl ammation followed by the release of plasma protease, lysosomes, and prostaglandins that induce pyrogen production, pain, and increase vascular permeability. This phase is the common target of most anti-infl ammatory drugs (Arul et al., 2004) . All doses of sample 1 have shown signifi cant reduction in the amount of leukocytes counted after carrageenan assault which was just similar to the effects of diclofenac. This could be attributed to the antihistaminic activity as indicated in the pharmacological description of diclofenac (MIMS, 2010) which inhibits the enzyme cyclooxygenase leading to decreased proinfl ammatory agents. Such action prevents from vasodilation and decreases the vascular permeability (Pendota et al., 2009) . Furthermore, the decreased level of histamine could potentially inhibit biosynthesis, release, and activity of prostaglandin.
A previous study (Simirgiotis et al., 2008) on S. samarangense crude extracts indicated its high analgesic and anti-infl ammatory properties. Sample 1 in this sense has an immense potential to reduce acute infl ammation by attenuated pleural exudation and migration of WBC caused by an irritant such as carrageenan. The current study suggests that sample 1 is also responsible for the high analgesic and anti-infl ammatory activities observed in this previous investigation of S. samarangense crude extracts.
Sample 1 did not cause any signifi cant effect on dechorionated 24-hpf and 36-hpf embryos. Treatments with sample 1, however, were found to have signifi cant effects on morphology and hatching frequency of embryos to intact chorion. Since direct exposure of the embryos to sample 1 did not reveal any observable difference to the negative control, it may have minimal contribution to the observed effects following the treatments. The presence of chorion allows the diffusion of gases (Iconomidou et al., 2000) . The overall integrity of the chorion may have been affected, thereby limiting the normal transit of materials such as respiratory gases (Mendelsohn et al., 2008) . Hypoxic condition in tissues may result in particular changes in the carbohydrate metabolism, a possible increase in the nitric oxide level, and stimulated production of hemoglobin (Padilla and Roth, 2001) . As demonstrated by Ton et al. (2003) zebrafi sh exposed to hypoxic conditions during development resulted in a shut-down of energy-requiring processes (i.e. protein synthesis), suppressed locomotion, and cell growth and division. Treatment with sample 1 may have created a hypoxic environment for the embryos due to a possible loss of chorionic integrity. Inhibition of the exchange of respiratory gases such as oxygen and carbon dioxide between the embryo and environment may have triggered certain teratologic switch. The chorion serves as the major respiratory organ upon which carbon dioxide and oxygen pass through (Mendelsohn et al., 2008) . As a result, the embryo is indirectly affected by sample 1 through disruption of the passage of gases needed for its development, causing very high mortality and a delay in hatching.
Conclusions
Sample 1 demonstrated analgesic activity at an effective dose of 6.25 mg/kg BW and anti-infl ammatory activity at an effective dose of 12.5 mg/kg BW, suggesting that it is of high pharmacological importance and could possibly be used as source of phytopharmaceuticals. The present study also demonstrated the relative toxicity potential of the mixture of sample 1 on zebrafi sh embryos in both dechorionated and intact chorion experiments. Sample 1 had no effect on the mortality and teratology of dechorionated zebrafi sh embryos. However, there were incidences but negligible abnormalities observed in all treatments. Hatching was delayed in embryos with intact chorion treated with sample 1, hence it is non-toxic at the dose tested. It has, however, a potential effect on chorionic membranes that may impair respiratory gas diffusion across the membrane system. Results of the study suggest the possible importance of sample 1 as bioactive substance capable of inhibiting pain sensitivity and infl ammation at a dose comparable to diclofenac with minimal to no effects on embryonic systems.
